Health
NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients – EurekAlert
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial, known as ACTIV-3, and as a ”master pro…
IMAGE: Colorized scanning electron micrograph of a cell (purple) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in…
view more
Credit: NIAID
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial is known as ACTIV-3, and as…
-
General16 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General21 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News20 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business19 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?